Wolfgang Singer is an associate professor of neurology at Mayo Clinic Rochester with interests in autonomic disorders and diseases caused by abnormal synuclein proteins. He graduated from medical school in Germany before completing residency and fellowship training at the Mayo Clinic in Rochester. Dr. Singer joined the Mayo Clinic staff in 2009 and his clinical and research interests focus on prodromal disease stages, discovery of novel biomarkers and novel treatment strategies. Dr. Singer is the director of Mayo Clinic’s Autonomic Laboratories, has chaired the Autonomic Section of the American Academy of Neurology, is currently president-elect of the American Autonomic Society and serves as co-chair of the recently established Unified MSA Rating Scale Task Force of the Movement Disorder Society. He also is member of the editorial board for the peer-reviewed, international biomedical journal Clinical Autonomic Research and Autonomic Neuroscience.
Associated Grants
-
Development of a Method for Assessing the Effectiveness of Alpha-synuclein Immunotherapy
2021